HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat.

Abstract
P2X3 and P2X2/3 receptors are highly localized on peripheral and central processes of sensory afferent nerves, and activation of these channels contributes to the pronociceptive effects of ATP. A-317491 is a novel non-nucleotide antagonist of P2X3 and P2X2/3 receptor activation. A-317491 potently blocked recombinant human and rat P2X3 and P2X2/3 receptor-mediated calcium flux (Ki = 22-92 nM) and was highly selective (IC50 >10 microM) over other P2 receptors and other neurotransmitter receptors, ion channels, and enzymes. A-317491 also blocked native P2X3 and P2X2/3 receptors in rat dorsal root ganglion neurons. Blockade of P2X3 containing channels was stereospecific because the R-enantiomer (A-317344) of A-317491 was significantly less active at P2X3 and P2X2/3 receptors. A-317491 dose-dependently (ED50 = 30 micromolkg s.c.) reduced complete Freund's adjuvant-induced thermal hyperalgesia in the rat. A-317491 was most potent (ED50 = 10-15 micromolkg s.c.) in attenuating both thermal hyperalgesia and mechanical allodynia after chronic nerve constriction injury. The R-enantiomer, A-317344, was inactive in these chronic pain models. Although active in chronic pain models, A-317491 was ineffective (ED50 >100 micromolkg s.c.) in reducing nociception in animal models of acute pain, postoperative pain, and visceral pain. The present data indicate that a potent and selective antagonist of P2X3 and P2X2/3 receptors effectively reduces both nerve injury and chronic inflammatory nociception, but P2X3 and P2X2/3 receptor activation may not be a major mediator of acute, acute inflammatory, or visceral pain.
AuthorsMichael F Jarvis, Edward C Burgard, Steve McGaraughty, Prisca Honore, Kevin Lynch, Timothy J Brennan, Alberto Subieta, Tim Van Biesen, Jayne Cartmell, Bruce Bianchi, Wende Niforatos, Karen Kage, Haixia Yu, Joe Mikusa, Carol T Wismer, Chang Z Zhu, Katharine Chu, Chih-Hung Lee, Andrew O Stewart, James Polakowski, Bryan F Cox, Elizabeth Kowaluk, Michael Williams, James Sullivan, Connie Faltynek
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 99 Issue 26 Pg. 17179-84 (Dec 24 2002) ISSN: 0027-8424 [Print] United States
PMID12482951 (Publication Type: Journal Article)
Chemical References
  • A-317491
  • Analgesics, Non-Narcotic
  • Anti-Inflammatory Agents, Non-Steroidal
  • P2RX2 protein, human
  • P2RX3 protein, human
  • P2rx2 protein, rat
  • P2rx3 protein, rat
  • Phenols
  • Polycyclic Compounds
  • Purinergic P2 Receptor Antagonists
  • Receptors, Purinergic P2X2
  • Receptors, Purinergic P2X3
Topics
  • Analgesics, Non-Narcotic (pharmacology)
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (pharmacology)
  • Brain (drug effects, physiology)
  • Dose-Response Relationship, Drug
  • Hemodynamics (drug effects)
  • Male
  • Motor Activity (drug effects)
  • Phenols (pharmacology)
  • Polycyclic Compounds (pharmacology)
  • Purinergic P2 Receptor Antagonists
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Purinergic P2X2
  • Receptors, Purinergic P2X3

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: